March 21, 2024
AMWA New England Chapter to host Spring Roundtables on Medical Writing Topics
Read MoreMarch 19, 2024
BioBridges has been engaged by an emerging, Boston-based biotech focusing on inflammatory diseases.
Read MoreMarch 12, 2024
A Seattle-based biotech client engaged BioBridges to provide a Quality Control professional.
Read MoreMarch 7, 2024
BioBridges has been engaged by a CAR-T-focused biotech company based in the San Francisco Bay Area.
Read MoreMarch 5, 2024
A Seattle-based biotech engaged BioBridges to provide a Quality Control professional to support their clinical regulatory writing team.
Read MoreFebruary 29, 2024
BioBridges has been engaged by a rare disease-focused biotech company based in the San Francisco Bay Area.
Read MoreFebruary 27, 2024
Boston-based gene therapy client cleared their first IND in rare disease indication.
Read MoreFebruary 22, 2024
BioBridges has been engaged by a Los Angeles-based biotech company to provide a GCP professional.
Read MoreFebruary 20, 2024
A clinical-stage, CAR-T-focused biotech, based in the San Francisco Bay Area, engaged BioBridges to provide data management support.
Read MoreFebruary 12, 2024
BioBridges has been engaged by an international, clinical-stage biopharmaceutical company to support their clinical coding activities.
Read MoreFebruary 12, 2024
A Boston-based early stage biotech company engaged BioBridges to provide project management support.
Read MoreFebruary 8, 2024
BioBridges has been engaged by a clinical-stage pharmaceutical company, based in Greater Boston.
Read MoreFebruary 5, 2024
BioBridges has been engaged by a large pharmaceutical company to provide medical writing support.
Read MoreJanuary 24, 2024
BioBridges has been engaged by an emergency cardiovascular company to provide an early stage clinical scientist.
Read MoreJanuary 16, 2024
BioBridges engaged for quality control and medical writing support.
Read MoreJanuary 10, 2024
BioBridges engages with a client in Southern California in need of biostatistical support.
Read MoreJanuary 2, 2024
BioBridges has been engaged by a “Big Pharma” company to provide medical writing support.
Read MoreDecember 19, 2023
BioBridges has been engaged by a Massachusetts based company, focused on rare diseases.
Read MoreDecember 12, 2023
A Global Biotechnology has Engaged BioBridges’ Medical Writers to Meet Timelines and to Support Regulatory Submissions.
Read MoreDecember 12, 2023
A clinical stage oncology biopharmaceutical company engaged a BioBridges medical writer to support FDA and global regulatory submissions.
Read MoreDecember 7, 2023
A late-stage immunology company engaged with BioBridges to provide GMP Quality Documentation Support.
Read MoreDecember 5, 2023
BioBridges has been engaged by a clinical stage biopharmaceutical company in Massachusetts.
Read MoreMarch 16, 2023
AMWA New England Chapter to host Medical Writing Roundtable
Read MoreJanuary 11, 2023
Is Relocation Really Worth It? Weighing The Pros and Cons of Biopharma Hot Spots
Read MoreNovember 22, 2022
Strategies to Keep Pace Amid Rapid Changes in Drug Development – By Jeff Souza, President and CEO of BioBridges
Read MoreJune 1, 2022
Early Strategizing Tightens Development Timelines
Read MoreApril 7, 2022
Alternatives to Permanent Employees
Read MoreApril 6, 2022
Health Tech: Jeff Souza On How BioBridges’ Technology Can Make An Important Impact On Our Overall Wellness
Read MoreApril 4, 2022
7 Strategies To Improve Clinical Trial Success
Read MoreNovember 29, 2021
BioBridges’ rapid growth prompts transition to larger headquarters in greater Boston.
Read MoreNovember 4, 2021
Common Pitfalls That Can Be Avoided During Clinical Development
Read MoreFebruary 22, 2021
BioBridges has been engaged by an established specialty pharmaceutical company, located in California.
Read MoreFebruary 17, 2021
BioBridges has been engaged by an established, Boston-based, biopharmaceutical company.
Read MoreFebruary 11, 2021
BioBridges has been engaged by an established, Boston-based, biopharmaceutical company.
Read MoreFebruary 10, 2021
BioBridges has been engaged by an established biopharmaceutical company, located near Boston.
Read MoreNovember 30, 2020
BioBridges has been engaged by an emerging biopharmaceutical company, located near the San Francisco Bay area.
Read MoreNovember 25, 2020
BioBridges has been engaged by an emerging biopharmaceutical company, located near Boston.
Read MoreNovember 23, 2020
BioBridges has been engaged by a Washington-based, biotechnology company.
Read MoreNovember 19, 2020
BioBridges has been engaged by an emerging, Seattle-based, biotechnology company.
Read MoreNovember 18, 2020
BioBridges has been engaged by an established, California-based, biotechnology company.
Read MoreNovember 16, 2020
BioBridges has been engaged by an established, Boston-based, biopharmaceutical company.
Read MoreNovember 13, 2020
BioBridges has been engaged by an established, Boston-based, biopharmaceutical company.
Read MoreNovember 11, 2020
BioBridges has been engaged by an established biopharmaceuticals company, located in New York.
Read MoreNovember 9, 2020
BioBridges has been engaged by an established biotechnology company, located near Boston.
Read MoreNovember 6, 2020
BioBridges has been engaged by an established, Boston-based, biopharmaceutical company.
Read MoreNovember 4, 2020
BioBridges has been engaged by an established biopharmaceutical company, located in Boston.
Read MoreAugust 7, 2020
BioBridges has been engaged by an established, Boston-based, biopharmaceutical company.
Read MoreAugust 6, 2020
BioBridges has been engaged by an emerging biotechnology company in Connecticut.
Read MoreAugust 4, 2020
BioBridges has been engaged by an established biopharmaceutical company in Boston.
Read MoreMarch 27, 2024
BioBridges has been engaged by a small-molecule focused biotech, located in Boulder.
Read MoreMarch 21, 2024
AMWA New England Chapter to host Spring Roundtables on Medical Writing Topics
Read MoreMarch 19, 2024
BioBridges has been engaged by an emerging, Boston-based biotech focusing on inflammatory diseases.
Read MoreMarch 12, 2024
A Seattle-based biotech client engaged BioBridges to provide a Quality Control professional.
Read MoreMarch 7, 2024
BioBridges has been engaged by a CAR-T-focused biotech company based in the San Francisco Bay Area.
Read MoreMarch 5, 2024
A Seattle-based biotech engaged BioBridges to provide a Quality Control professional to support their clinical regulatory writing team.
Read MoreFebruary 29, 2024
BioBridges has been engaged by a rare disease-focused biotech company based in the San Francisco Bay Area.
Read MoreFebruary 27, 2024
Boston-based gene therapy client cleared their first IND in rare disease indication.
Read MoreFebruary 22, 2024
BioBridges has been engaged by a Los Angeles-based biotech company to provide a GCP professional.
Read MoreFebruary 20, 2024
A clinical-stage, CAR-T-focused biotech, based in the San Francisco Bay Area, engaged BioBridges to provide data management support.
Read MoreFebruary 12, 2024
BioBridges has been engaged by an international, clinical-stage biopharmaceutical company to support their clinical coding activities.
Read MoreFebruary 12, 2024
A Boston-based early stage biotech company engaged BioBridges to provide project management support.
Read MoreFebruary 8, 2024
BioBridges has been engaged by a clinical-stage pharmaceutical company, based in Greater Boston.
Read MoreFebruary 5, 2024
BioBridges has been engaged by a large pharmaceutical company to provide medical writing support.
Read MoreJanuary 24, 2024
BioBridges has been engaged by an emergency cardiovascular company to provide an early stage clinical scientist.
Read MoreJanuary 16, 2024
BioBridges engaged for quality control and medical writing support.
Read MoreJanuary 10, 2024
BioBridges engages with a client in Southern California in need of biostatistical support.
Read MoreJanuary 2, 2024
BioBridges has been engaged by a “Big Pharma” company to provide medical writing support.
Read MoreDecember 19, 2023
BioBridges has been engaged by a Massachusetts based company, focused on rare diseases.
Read MoreDecember 12, 2023
A Global Biotechnology has Engaged BioBridges’ Medical Writers to Meet Timelines and to Support Regulatory Submissions.
Read MoreDecember 12, 2023
A clinical stage oncology biopharmaceutical company engaged a BioBridges medical writer to support FDA and global regulatory submissions.
Read MoreDecember 7, 2023
A late-stage immunology company engaged with BioBridges to provide GMP Quality Documentation Support.
Read MoreDecember 5, 2023
BioBridges has been engaged by a clinical stage biopharmaceutical company in Massachusetts.
Read MoreMarch 16, 2023
AMWA New England Chapter to host Medical Writing Roundtable
Read MoreJanuary 11, 2023
Is Relocation Really Worth It? Weighing The Pros and Cons of Biopharma Hot Spots
Read MoreNovember 22, 2022
Strategies to Keep Pace Amid Rapid Changes in Drug Development – By Jeff Souza, President and CEO of BioBridges
Read MoreJune 1, 2022
Early Strategizing Tightens Development Timelines
Read MoreApril 7, 2022
Alternatives to Permanent Employees
Read MoreApril 6, 2022
Health Tech: Jeff Souza On How BioBridges’ Technology Can Make An Important Impact On Our Overall Wellness
Read MoreApril 4, 2022
7 Strategies To Improve Clinical Trial Success
Read MoreNovember 29, 2021
BioBridges’ rapid growth prompts transition to larger headquarters in greater Boston.
Read MoreNovember 4, 2021
Common Pitfalls That Can Be Avoided During Clinical Development
Read MoreFebruary 22, 2021
BioBridges has been engaged by an established specialty pharmaceutical company, located in California.
Read MoreFebruary 17, 2021
BioBridges has been engaged by an established, Boston-based, biopharmaceutical company.
Read MoreFebruary 11, 2021
BioBridges has been engaged by an established, Boston-based, biopharmaceutical company.
Read MoreFebruary 10, 2021
BioBridges has been engaged by an established biopharmaceutical company, located near Boston.
Read MoreNovember 30, 2020
BioBridges has been engaged by an emerging biopharmaceutical company, located near the San Francisco Bay area.
Read MoreNovember 25, 2020
BioBridges has been engaged by an emerging biopharmaceutical company, located near Boston.
Read MoreNovember 23, 2020
BioBridges has been engaged by a Washington-based, biotechnology company.
Read MoreNovember 19, 2020
BioBridges has been engaged by an emerging, Seattle-based, biotechnology company.
Read MoreNovember 18, 2020
BioBridges has been engaged by an established, California-based, biotechnology company.
Read MoreNovember 16, 2020
BioBridges has been engaged by an established, Boston-based, biopharmaceutical company.
Read MoreNovember 13, 2020
BioBridges has been engaged by an established, Boston-based, biopharmaceutical company.
Read MoreNovember 11, 2020
BioBridges has been engaged by an established biopharmaceuticals company, located in New York.
Read MoreNovember 9, 2020
BioBridges has been engaged by an established biotechnology company, located near Boston.
Read MoreNovember 6, 2020
BioBridges has been engaged by an established, Boston-based, biopharmaceutical company.
Read MoreNovember 4, 2020
BioBridges has been engaged by an established biopharmaceutical company, located in Boston.
Read MoreAugust 7, 2020
BioBridges has been engaged by an established, Boston-based, biopharmaceutical company.
Read MoreAugust 6, 2020
BioBridges has been engaged by an emerging biotechnology company in Connecticut.
Read MoreAugust 4, 2020
BioBridges has been engaged by an established biopharmaceutical company in Boston.
Read MoreReady to begin?
Let's talk about how our clinical experts can help your clinical trial run as efficiently and effectively as possible.